Drug    DrugBank | All Description Patterns💬 Info on mouse-over

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	Disease ID
1	Ambrisentan plus spironolactone	Ambrisentan	[2] D00443, D07077 💬	[2] EDNRA, NR3C2 💬	[8] Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	[1] 86 💬
2	Spironolactone	Spironolactone	[1] D00443 💬	[1] NR3C2 💬	[1] Aldosterone-regulated sodium reabsorption	[7] 58, 67, 86, 113, 210, 218, 225 💬
3	Spironolactone (drug)	Spironolactone	[1] D00443 💬	[1] NR3C2 💬	[1] Aldosterone-regulated sodium reabsorption	[1] 210 💬
4	Spironolactone and conivaptan	Conivaptan	[3] D00443, D01236, D07748 💬	[3] AVPR1A, AVPR2, NR3C2 💬	[6] Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption	[1] 86 💬
5	Spironolactone captopril carvedilol	Captopril	[4] D00251, D00255, D00443, D03415 💬	[7] ACE, ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, NR3C2 💬	[18] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway	[1] 86 💬